Resources

Explore comprehensive data, application notes, and posters highlighting the G4 Sequencing Platform’s performance and capabilities.

Applications

RNA Sequencing

RNA sequencing (RNA-Seq) is used to assess differential gene expression profiles, detect novel transcripts, and characterize new splice variants or cell types. Explore how the reimagined chemistry and advanced engineering of the G4 can improve your RNA sequencing.

Single Cell RNA Sequencing

Single cell RNA sequencing (scRNA-Seq) has revolutionized basic and translational research in immunology, developmental biology and cancer by enabling the resolution of distinct cell populations within heterogeneous samples. Explore how the G4 can seamlessly integrate into your scRNA-Seq workflow and accelerate your results without sacrificing accuracy.

Whole Exome Sequencing

Whole exome sequencing (WES) is a next-generation sequencing method used to discover and assess genetic variations linked to rare or complex diseases. Learn how the G4 provides excellent variant-calling accuracy and unmatched speed and versatility to labs performing WES.

Whole Genome Sequencing

Whole genome sequencing (WGS) is the process for analyzing the complete genetic makeup of an organism. Learn more about the suitability of the G4 for human whole genome sequencing in the WGS technical report.

Videos

Introducing the G4 Sequencing Platform | The World's Most Powerful Benchtop Sequencer
Delivering Fast, Flexible Next Generation Sequencing Through Innovations in Chemistry and Engineering
Advancing Speed, Versatility, and Accuracy in Next-Generation Sequencing | PMWC Conference 2022

Posters & Publications

AMP 2022

Performance Assessment of the G4 Sequencing Platform for Rapid and Flexible Next Generation Sequencing

by Singular Genomics (Kenneth Gouin III et al.)

AMP 2022

Ring-Seq: A Novel Technology for Multiplex PCR Based Detection of Gene Fusions with Novel Partners and Breakpoints from Highly Degraded Material

by Singular Genomics (Richard Que et al.)

ASHG 2022

Max Read: A Novel High-Throughput Short-Read Format for the G4™ Sequencing Platform

by Singular Genomics (Niek van Wietmarschen et al.)

ASHG 2022

Single Cell RNA Sequencing with the G4™ Sequencing Platform

by Singular Genomics (Kenneth Gouin III et al.)

AGBT 2022

Singular Genomics’ G4 Platform Technology Assessment

by TGEN (Candice L. Wilke et al.)

AGBT 2022

Training and Validation of an Accelerated DeepVariant Model for Germline Exome Analysis on the G4

by Singular Genomics (Kenneth Gouin III et al.)

AMP 2022

Rapid Targeted Germline and Somatic Variant Detection Using the G4™ Sequencing Platform

by Singular Genomics (Kenneth Gouin III et al.)

ASHG 2022

Rapid Whole Genome and Whole Exome Variant Detection Using a Novel Fluorescently Labeled Reversible Terminated Nucleotide Sequencing System and GPU-based Accelerated Analysis

by Singular Genomics (Kenneth Gouin III et al.)

ASHG 2022

HD-Seq: A Novel Method for High Accuracy Sequencing

by Singular Genomics (Sabrina Shore et al.)

AGBT 2022

Bacterial Whole Genome Assembly and Microbial Community Analysis with the G4

by JGI (Christopher G. Daum et al.)

AGBT 2022

Evaluation of the Singular Genomics G4 Sequencing Platform with Resolution ctDx Assays on Cell-Free DNA

by Resolution Biosciences (Carolyn Hutcheon et al.)

bioRxiv, 2022

XR-Seq: Reconstruction of Full-Length scFv Libraries with the Extended Range Targeted Sequencing Method

(Christopher Wei et al.)

Innovation with Intention

Featuring novel, high-performance chemistry and advanced engineering, the G4 Sequencing Platform has been optimized to deliver speed, power, unprecedented flexibility, and accuracy.

Download RNA-Seq App Note

Please take a moment to provide some information prior to downloading the RNA-Seq App note.

Download Single Cell RNA-Seq Application Note

Please provide your information to download the app note.

Download Whole Exome Sequencing App Note

Please provide your information to download the exome sequencing app note.

Download WGS Tech Report

Explore and download the G4 Sequencer’s coverage, quality, accuracy and variant calling performance for Whole Genome Sequencing.

Download G4 Performance Assessment Poster

Please provide your information to download the poster.

Download Ring-Seq Poster

Please provide your information to download the poster.

Download Max Read Poster

Please provide your information to download the poster.

Download Singular Genomics Single Cell RNA-Seq Poster

Please provide your information to download the poster.

Download TGen Poster

Please provide your information to download the poster.

Download the Accelerated DeepVariant Model for Germline Exome Analysis Poster

Please provide your information to download the whole exome poster.

Download Rapid Targeted Germline and Somatic Variant Detection Poster

Please provide your information to download the poster.

Download the Whole Genome and Whole Exome Variant Poster

Please provide your information to download the poster.

Download the HD-Seq Poster

Please provide your information to download the poster.

Download JGI Poster

Please provide your information to download the JGI poster.

Download Resolution Bioscience Poster

Please provide your information to download the poster.

Download XR-Seq Publication

Please provide your information to view and download the publication.

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.

Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Max Reads Application Note